Dexcom Inc
XBER:DC4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dexcom Inc
XBER:DC4
|
US |
|
Prologis Property Mexico SA de CV
OTC:FBBPF
|
MX |
|
C
|
Coca-Cola Femsa SAB de CV
F:CFSL
|
MX |
|
L
|
Lubelski Wegiel Bogdanka SA
XMUN:UXX
|
PL |
|
N
|
NETGEAR Inc
F:NGJ
|
US |
|
A
|
Apollo Medical Holdings Inc
F:3AM
|
US |
|
M
|
Medios AG
F:ILM1
|
DE |
|
K
|
Kalvista Pharmaceuticals Inc
SWB:4XC1
|
US |
|
P
|
Pentamaster Corporation Bhd
KLSE:PENTA
|
MY |
|
O
|
OGE Energy Corp
F:OG5
|
US |
|
V
|
ViTrox Corporation Bhd
KLSE:VITROX
|
MY |
|
B
|
Baloise Holding AG
XMUN:BLON
|
CH |
Wall St Price Targets
DC4 Price Targets Summary
Dexcom Inc
According to Wall Street analysts, the average 1-year price target for DC4 is 67.96 EUR with a low forecast of 53.16 EUR and a high forecast of 92.38 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DC4's stock price target?
Price Target
67.96
EUR
According to Wall Street analysts, the average 1-year price target for DC4 is 67.96 EUR with a low forecast of 53.16 EUR and a high forecast of 92.38 EUR.
What is the Revenue forecast for Dexcom Inc?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 5 years is 12%.
What is the Operating Income forecast for Dexcom Inc?
Projected CAGR
19%
The compound annual growth rate for Operating Income over the next 5 years is 19%.
What is the Net Income forecast for Dexcom Inc?
Projected CAGR
19%
The compound annual growth rate for Net Income over the next 5 years is 19%.
